biOasis Technologies Ord Shs V.BTI.H

20-day volume weighted average price

[prophetoffactz]

• The purchase price of the Private Placement will be the lower of (i) US$1.00 (the previously agreed purchase price) and (ii) the 20-day volume weighted average price on the last business day prior to Completion ("VWAP") less 10%;
• If the 20-day VWAP prior to Closing is less than $0.90, the Company may terminate the Private Placement without penalty; and

----------

Midatech tweet:

 @Midatech

·

Dec 23

 

From our team at #MidatechPharma, we would like to wish all of you a very Merry Christmas and a Happy 2023! Our office will be closed until January 3rd. For any urgent matters, please contact [e-mail]. We look forward to the successes the New Year will bring!

[prophetoffactz]

So if they've been on holidays until Jan.3 and January sets the 20-day volume weighted price what happens in January?

[narmac]

Clearly this corporate raid deserves a big NO vote from retail shareholders!!  Patience is our virtue! Allow 2023 to determine if there is value in our xB3 platform.  Lets not allow this pitiful, disrespectful and incompetent arrangemnt to define us! It defines what type of leadership we have had. No wonder we were becalmed! We need to retian Dr. Mei Mei !!  The BoDs can go and I

[Boomskid]

Pof, we know you're an expert on these things, so, really, does the price of the financing, and whether Armistice has 56.6% of Biodexa or 66.6% of Biodexa, make any difference to Bioasis shareholders? I mean, the symbolism of that latter number notwithstanding?   It's been bothering me since the beginning, but if this deal collapses, who would benefit? It looks like Lind to me